Beren Therapeutics
PrivateLast Round
VC Round
Jun 10, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beren Therapeutics is a biotechnology company that develops cyclodextrin-based therapeutics for conditions characterized by defective cholesterol trafficking, such as Niemann-Pick disease type C.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B2C
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beren Therapeutics Comparables
Compare Beren Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ventus Therapeutics | 84% | |
| NodThera | 81% | |
| Brenig Therapeutics | 80% | |
Beren Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 10, 2026 | ||||
| Corporate Funding | May 23, 2023 |
Key People
Founding team and executive leadership
Beren Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | VC Round |
| Narya Capital | VC Round |
| Gaingels | VC Round |
| Founders Fund | VC Round |
| JIC Venture Growth Investments | VC Round |
| Wellington Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Grew 24% QoQ, from 83 to 103 employees.
- Jun 10, 2026
$135M raised with participation from Founders Fund.
Beren Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beren Therapeutics's valuation, stock price, and market status.